Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FLD | FOLD HOLDINGS INC | $29.85M | $0.54 | $1.80 | 232.10% | Strong Buy | 3 | 3.24% | N/A | -68.54% | -40.80% | |||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | $1.30B | $36.44 | $60.50 | 66.03% | Strong Buy | 8 | N/A | N/A | -84.75% | -78.11% | |||
| PAC | PACIFIC AIRPORT GROUP | $10.28B | $203.46 | $261.67 | 28.61% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| CABA | CABALETTA BIO INC | $462.86M | $2.73 | $15.60 | 471.43% | Strong Buy | 5 | N/A | N/A | -87.05% | -71.40% | |||
| AGMB | AGOMAB THERAPEUTICS NV | $636.50M | $13.06 | $43.00 | 229.25% | Strong Buy | 4 | N/A | N/A | -25.84% | -23.57% | |||
| IRON | DISC MEDICINE INC | $2.69B | $70.06 | $101.67 | 45.11% | Strong Buy | 3 | N/A | N/A | -16.19% | -14.19% | |||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $11.70B | $82.85 | $102.09 | 23.22% | Strong Buy | 11 | -3.86% | N/A | -65.12% | -14.35% | |||
| LONA | LEONABIO INC | $65.20M | $6.92 | $17.33 | 150.48% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| IMMX | IMMIX BIOPHARMA INC | $868.49M | $12.14 | $21.67 | 78.48% | Strong Buy | 6 | N/A | N/A | 16.42% | 15.72% | |||
| SKHY | SK HYNIX INC | N/A | $190.07 | $248.00 | 30.48% | Strong Buy | 9 | N/A | N/A | N/A | N/A | |||
| RBRK | RUBRIK INC | $17.96B | $86.65 | $109.87 | 26.80% | Strong Buy | 23 | 10.09% | N/A | -45.50% | 7.98% | |||
| TLX | TELIX PHARMACEUTICALS LTD | $3.84B | $11.29 | $21.33 | 88.95% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| VKTX | VIKING THERAPEUTICS INC | $3.73B | $31.98 | $99.17 | 210.09% | Strong Buy | 6 | N/A | N/A | -43.00% | -33.64% | |||
| BRSP | BRIGHTSPIRE CAPITAL INC | $563.03M | $4.45 | $6.67 | 49.82% | Strong Buy | 3 | -36.86% | N/A | 9.42% | 2.17% | |||
| ERAS | ERASCA INC | $5.55B | $15.88 | $22.56 | 42.04% | Strong Buy | 9 | N/A | N/A | -75.17% | -62.52% | |||
| ARVN | ARVINAS INC | $552.51M | $8.45 | $16.29 | 92.73% | Strong Buy | 7 | -35.50% | N/A | -24.71% | -20.58% | |||
| BLND | BLEND LABS INC | $333.48M | $1.41 | $2.98 | 110.99% | Strong Buy | 4 | 5.36% | N/A | -39.46% | 20.44% | |||
| INFQ | INFLEQTION INC | $2.96B | $13.12 | $21.40 | 63.11% | Strong Buy | 5 | 9.70% | N/A | N/A | N/A | |||
| ACRS | ACLARIS THERAPEUTICS INC | $783.10M | $5.32 | $11.50 | 116.17% | Strong Buy | 6 | -11.17% | N/A | -106.29% | -73.69% | |||
| IPX | IPERIONX LTD | $627.91M | $18.67 | $44.33 | 137.46% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| ADTN | ADTRAN HOLDINGS INC | $614.37M | $7.54 | $15.25 | 102.25% | Strong Buy | 4 | 6.24% | N/A | N/A | N/A | |||
| LTRX | LANTRONIX INC | $244.74M | $5.24 | $11.33 | 116.28% | Strong Buy | 3 | 12.62% | N/A | N/A | N/A | |||
| CNTX | CONTEXT THERAPEUTICS INC | $32.16M | $0.35 | $6.25 | 1,685.71% | Strong Buy | 4 | N/A | N/A | -116.86% | -96.69% | |||
| ATHE | ALTERITY THERAPEUTICS LTD | $73.12M | $4.05 | $12.67 | 212.77% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| SGRY | SURGERY PARTNERS INC | $1.88B | $14.38 | $18.67 | 29.81% | Strong Buy | 3 | 3.00% | N/A | 9.43% | 1.96% | |||
| COAG | HEMAB THERAPEUTICS HOLDINGS INC | $1.84B | $39.40 | $51.40 | 30.46% | Strong Buy | 5 | N/A | N/A | -39.96% | -38.81% | |||
| BWAY | BRAINSWAY LTD | $545.58M | $13.93 | $19.27 | 38.31% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| ELAN | ELANCO ANIMAL HEALTH INC | $11.58B | $23.17 | $30.33 | 30.91% | Strong Buy | 6 | 4.83% | N/A | 11.27% | 5.47% | |||
| NKTX | NKARTA INC | $208.43M | $2.91 | $11.75 | 303.78% | Strong Buy | 4 | N/A | N/A | -42.32% | -31.05% | |||
| BTGO | BITGO HOLDINGS INC | $899.22M | $7.65 | $11.50 | 50.33% | Strong Buy | 9 | -74.36% | N/A | 18.54% | 1.30% | |||
| BIOA | BIOAGE LABS INC | $389.66M | $8.49 | $33.33 | 292.61% | Strong Buy | 3 | -29.29% | N/A | -45.11% | -42.61% | |||
| GENB | GENERATE BIOMEDICINES INC | $2.02B | $15.72 | $26.40 | 67.94% | Strong Buy | 6 | N/A | N/A | -56.55% | -45.92% | |||
| ZGN | ERMENEGILDO ZEGNA NV | $3.12B | $11.61 | $14.83 | 27.76% | Strong Buy | 3 | 1.19% | N/A | 11.76% | 3.95% | |||
| VCYT | VERACYTE INC | $3.29B | $40.87 | $55.44 | 35.66% | Strong Buy | 9 | 9.69% | 0.25% | 11.84% | 11.06% | |||
| ABVX | ABIVAX SA | $9.37B | $118.64 | $154.30 | 30.06% | Strong Buy | 10 | N/A | N/A | N/A | N/A | |||
| TYRA | TYRA BIOSCIENCES INC | $1.31B | $22.03 | $48.71 | 121.13% | Strong Buy | 8 | N/A | N/A | -49.05% | -45.25% | |||
| AKTS | AKTIS ONCOLOGY INC | $1.30B | $23.30 | $36.67 | 57.37% | Strong Buy | 7 | N/A | N/A | -37.68% | -32.76% | |||
| CEVA | CEVA INC | $816.75M | $29.01 | $44.14 | 52.16% | Strong Buy | 8 | 11.79% | N/A | 9.17% | 7.96% | |||
| LTM | LATAM AIRLINES GROUP SA | $29.45B | $51.29 | $65.00 | 26.73% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $267.01M | $9.16 | $13.00 | 41.92% | Strong Buy | 8 | N/A | N/A | N/A | N/A | |||
| KARD | KARDIGAN INC | $1.73B | $18.52 | $42.25 | 128.13% | Strong Buy | 4 | N/A | N/A | -58.45% | -49.85% | |||
| SLDB | SOLID BIOSCIENCES INC | $932.86M | $8.70 | $19.67 | 126.06% | Strong Buy | 9 | N/A | N/A | -3.12% | -2.77% | |||
| QNT | QUANTINUUM INC | $12.91B | $49.03 | $98.83 | 101.58% | Strong Buy | 13 | N/A | N/A | -78.45% | -10.03% | |||
| SVCO | SILVACO GROUP INC | $227.37M | $6.71 | $12.67 | 88.78% | Strong Buy | 3 | 6.56% | N/A | 12.19% | 8.84% | |||
| KRRO | KORRO BIO INC | $203.36M | $13.81 | $20.25 | 46.63% | Strong Buy | 4 | -58.88% | N/A | -81.10% | -51.22% | |||
| CX | CEMEX SAB DE CV | $15.51B | $10.69 | $14.60 | 36.58% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| CGEM | CULLINAN THERAPEUTICS INC | $1.33B | $20.59 | $37.00 | 79.70% | Strong Buy | 3 | N/A | N/A | -57.33% | -50.70% | |||
| OMAB | CENTRAL NORTH AIRPORT GROUP | $4.77B | $98.73 | $134.00 | 35.72% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $320.77M | $2.81 | $11.44 | 307.26% | Strong Buy | 9 | -9.53% | N/A | -35.95% | -29.70% | |||
| JHX | JAMES HARDIE INDUSTRIES PLC | $16.53B | $28.47 | $35.20 | 23.64% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| PAAS | PAN AMERICAN SILVER CORP | $21.21B | $50.34 | $67.25 | 33.59% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| CLS | CELESTICA INC | $39.85B | $346.55 | $450.46 | 29.98% | Strong Buy | 13 | N/A | N/A | N/A | N/A | |||
| CRVO | CERVOMED INC | $38.86M | $2.57 | $21.20 | 724.90% | Strong Buy | 5 | -100.00% | N/A | -72.54% | -64.08% | |||
| KLRA | KAILERA THERAPEUTICS INC | $1.81B | $13.94 | $38.00 | 172.60% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| MAZE | MAZE THERAPEUTICS INC | $1.37B | $24.60 | $67.20 | 173.17% | Strong Buy | 5 | -28.52% | N/A | -48.18% | -41.07% | |||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $727.57M | $13.17 | $31.00 | 135.38% | Strong Buy | 5 | -19.01% | N/A | -41.57% | -34.40% | |||
| MSLE | SATELLOS BIOSCIENCE INC | $203.18M | $9.75 | $20.33 | 108.54% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $894.23M | $10.22 | $40.50 | 296.28% | Strong Buy | 7 | N/A | N/A | -44.98% | -39.80% | |||
| HELP | CYBIN INC | $803.93M | $12.97 | $47.50 | 266.23% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| ELOX | ELOXX PHARMACEUTICALS INC | $63.57M | $15.75 | $40.33 | 156.08% | Strong Buy | 3 | N/A | N/A | -22.75% | -16.66% | |||
| SGMT | SAGIMET BIOSCIENCES INC | $676.29M | $10.88 | $27.95 | 156.91% | Strong Buy | 6 | N/A | N/A | -25.28% | -24.58% | |||
| NVCT | NUVECTIS PHARMA INC | $781.63M | $23.99 | $36.00 | 50.06% | Strong Buy | 3 | N/A | N/A | -541.57% | -219.81% | |||
| ATTO | ATTOVIA THERAPEUTICS INC | $1.04B | $22.79 | $41.50 | 82.10% | Strong Buy | 4 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.